Below are the top 10 best-rated Micro Cap stocks (market cap < $300 million), based on the number of positive ratings by brokerage analysts. One Chinese company (WATG) is on the list.
Comverge, Inc. (NASDAQ:COMV) is the 1st best-rated stock in this segment of the market. It is rated positively by 10 brokerage analysts. It is covered by 18 brokerage analysts. Sierra Wireless, Inc. (USA) (NASDAQ:SWIR) is the 2nd best-rated stock in this segment of the market. It is rated positively by 10 brokerage analysts. It is covered by 18 brokerage analysts. Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) is the 3rd best-rated stock in this segment of the market. It is rated positively by 9 brokerage analysts. It is covered by 13 brokerage analysts. Crude Carriers Corp. (NYSE:CRU) is the 4th best-rated stock in this segment of the market. It is rated positively by 8 brokerage analysts. It is covered by 8 brokerage analysts. Clarient, Inc. (NASDAQ:CLRT) is the 5th best-rated stock in this segment of the market. It is rated positively by 8 brokerage analysts. It is covered by 9 brokerage analysts.
OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) is the 6th best-rated stock in this segment of the market. It is rated positively by 8 brokerage analysts. It is covered by 9 brokerage analysts. Wonder Auto Technology, Inc. (NASDAQ:WATG) is the 7th best-rated stock in this segment of the market. It is rated positively by 8 brokerage analysts. It is covered by 10 brokerage analysts. Augusta Resource Corp. (USA) (AMEX:AZC) is the 8th best-rated stock in this segment of the market. It is rated positively by 7 brokerage analysts. It is covered by 7 brokerage analysts. Dyax Corp. (NASDAQ:DYAX) is the 9th best-rated stock in this segment of the market. It is rated positively by 7 brokerage analysts. It is covered by 7 brokerage analysts. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is the 10th best-rated stock in this segment of the market. It is rated positively by 7 brokerage analysts. It is covered by 9 brokerage analysts.
Source:cnanalyst
No comments:
Post a Comment